Clinical Trials
3 trialsNCT04192344 2026-03-19
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
Abbisko Therapeutics Co, Ltd
Phase 1 Recruiting
NCT01804530 2018-08-02
Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors
Plexxikon
Phase 1 Terminated
NCT02673736 2018-08-02
A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor
Plexxikon
Phase 1 Terminated